TAF to prevent hepatitis B transmission during pregnancy
Part of Digestive system, Infections clinical trials.
This study tests whether a daily antiviral pill called TAF can reduce the risk of passing hepatitis B to your baby. It is for pregnant women with high levels of the virus who are between 24 and 28 weeks along.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 to 40 years old.
- You have had hepatitis B for at least 6 months (HBsAg positive).
- Your hepatitis B viral load is very high (200,000 IU/mL or more).
- You are between 24 and 28 weeks pregnant.
- You have not taken antiviral medications for hepatitis B before.
- You are willing to take a daily pill (TAF) to lower the chance of passing hepatitis B to your baby.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests tenofovir alafenamide (TAF) to lower hepatitis B in pregnant people and reduce the chance of passing it to the baby. You may be able to join if you’re pregnant with active hepatitis B and meet safety lab and pregnancy ultrasound requirements.
This study looks at how well different hepatitis B treatments help lower the risk of liver cancer. It's for people with chronic hepatitis B who are already using or starting certain antiviral or interferon therapies.
This study tests a new pill called ZM-H1505R added to your current daily oral antiviral to see if it can better control hepatitis B virus. It's for people whose virus is still active despite standard treatment.
This study compares two antiviral medications (TAF and TDF) in pregnant women with hepatitis B to see which is safer and more effective during pregnancy and for the baby's health.
This trial tests if TAF is safer and as effective as TDF for pregnant women with high hepatitis B viral loads to prevent passing the virus to their babies. You may qualify if you are pregnant, between 20-28 weeks, and have high viral levels.
This trial tests a hepatitis B medicine called TAF in pregnant women who need antiviral treatment. It helps protect both mom and baby from complications of the virus.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.